Gilead wins reversal in $2.5 billion dispute with Merck
Judge overturns jury award that centered on breakthrough hepatitis C active ingredient sofosbuvir
Source: Chemical and Engineering News - Category: Chemistry Authors: Marc S. Reisch Source Type: research